Genesystem Co., Ltd. (KOSDAQ: 363250)
South Korea
· Delayed Price · Currency is KRW 8,820.00
-230.00 (-2.54%)
Dec 19, 2024, 1:59 PM KST
Genesystem Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Sep '23 Sep 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Operating Revenue | 1,566 | 3,653 | 13,237 | 13,258 | 1,135 |
| Other Revenue | 0 | - | - | -0 | - |
| Revenue | 1,566 | 3,653 | 13,237 | 13,258 | 1,135 |
| Revenue Growth (YoY) | -78.04% | -72.40% | -0.16% | 1068.27% | - |
| Cost of Revenue | 2,471 | 2,486 | 4,571 | 4,271 | 819.35 |
| Gross Profit | -904.72 | 1,167 | 8,666 | 8,987 | 315.52 |
| Selling, General & Admin | 4,181 | 3,855 | 3,319 | 3,858 | 1,295 |
| Research & Development | 3,471 | 3,354 | 2,842 | 1,631 | 1,199 |
| Other Operating Expenses | 75.55 | 72.81 | 57.64 | 41.43 | 13.3 |
| Operating Expenses | 8,147 | 7,772 | 6,400 | 5,622 | 2,810 |
| Operating Income | -9,052 | -6,605 | 2,266 | 3,365 | -2,494 |
| Interest Expense | -124.18 | -95.47 | -88.86 | -445.55 | -552.59 |
| Interest & Investment Income | 339.47 | 205.31 | 71.39 | 1.55 | 2.08 |
| Currency Exchange Gain (Loss) | -12.62 | 234.36 | 969.61 | -764.99 | 1.73 |
| Other Non Operating Income (Expenses) | 68.51 | 29.27 | -44.87 | -5,748 | -998.01 |
| EBT Excluding Unusual Items | -8,919 | -6,231 | 3,173 | -3,592 | -4,041 |
| Gain (Loss) on Sale of Investments | -391.76 | -825.27 | -8.59 | - | - |
| Gain (Loss) on Sale of Assets | -3.14 | -3.14 | -0 | - | - |
| Pretax Income | -9,314 | -7,060 | 3,165 | -3,592 | -4,041 |
| Income Tax Expense | 1,951 | 1,936 | -386.59 | -1,368 | - |
| Net Income | -11,266 | -8,996 | 3,551 | -2,224 | -4,041 |
| Net Income to Common | -11,266 | -8,996 | 3,551 | -2,224 | -4,041 |
| Shares Outstanding (Basic) | 7 | 7 | 6 | 4 | 2 |
| Shares Outstanding (Diluted) | 7 | 7 | 6 | 4 | 2 |
| Shares Change (YoY) | 1.05% | 7.66% | 69.48% | 71.10% | - |
| EPS (Basic) | -1623.49 | -1303.50 | 568.00 | -588.00 | -1828.00 |
| EPS (Diluted) | -1623.49 | -1303.50 | 554.00 | -588.00 | -1828.00 |
| Free Cash Flow | -7,532 | -6,655 | 661.76 | -2,044 | -2,229 |
| Free Cash Flow Per Share | -1085.38 | -964.32 | 103.23 | -540.36 | -1008.42 |
| Gross Margin | -57.76% | 31.96% | 65.47% | 67.78% | 27.80% |
| Operating Margin | -577.83% | -180.80% | 17.12% | 25.38% | -219.78% |
| Profit Margin | -719.17% | -246.26% | 26.83% | -16.77% | -356.08% |
| Free Cash Flow Margin | -480.80% | -182.18% | 5.00% | -15.42% | -196.43% |
| EBITDA | -8,641 | -6,219 | 2,574 | 3,615 | -2,358 |
| EBITDA Margin | - | -170.23% | 19.45% | 27.26% | -207.80% |
| D&A For EBITDA | 410.46 | 386.3 | 308.08 | 249.82 | 135.93 |
| EBIT | -9,052 | -6,605 | 2,266 | 3,365 | -2,494 |
| EBIT Margin | - | -180.80% | 17.12% | 25.38% | -219.78% |
| Advertising Expenses | - | 239.36 | 133.19 | 111.97 | 66.9 |
Source: S&P Capital IQ. Standard template. Financial Sources.